Metagenomi Inc. (MGX): Revenue Growth QoQ

Corporate company logo of Metagenomi (MGX)

Metagenomi, Inc. (MGX) ensures the continuity of biocomponent supplies through global resource diversification. The scaling of its IT platform and B2B partnerships are aimed at expansion within the precision genome editing segment. The quarterly revenue growth rate visualizes the dynamics of these processes, where -75.30 determines the current status of the parameter. Business resilience is based on a robust intellectual property portfolio and the potential of gene therapy.

MGX (Metagenomi Therapeutics) Quarterly Sales Growth history from 02/21/2024 to 11/20/2026

MGX (Metagenomi): analytical breakdowns and indicator data

- stock price and consensus target price:
- stock exchange capitalization data:
- cash and cash flow metrics:
Comprehensive company analysis:Metagenomi - MGX
Mass-produced product of metagenomi.co

For Metagenomi, Inc. (MGX), which attracts top geneticists to advance CRISPR technologies, revenue dynamics reflect the efficiency of commercializing scientific discoveries and the stability of partnerships with pharma behemoths. By analyzing the quarterly revenue growth rate, an investor assesses the percentage change in sales between the current and previous quarter, which helps identify seasonality or the cyclicality of cash flows, confirming the fundamental stability and asset quality of the company.

Direct competitors

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|Regenxbio (RGNX) - Revenue Growth QoQ|SLDB - Quarterly Sales Growth Rate|OCGN (Ocugen Inc) - Quarterly Revenue Growth|Revenue Growth QoQ PACB|Revenue Growth QoQ Benitec (BNTC)|Design Therapeutics Inc - Sales Growth QoQ|Revenue Growth QoQ Rocket Pharma RCKT|Quarterly Revenue Growth 4DMT FDMT|LXEO - Revenue Growth QoQ|Quarterly Revenue Growth Rate Korro Bio Inc.|EDIT: Quarterly Revenue Growth|SLN - Quarterly Sales Growth Rate|PRQR (ProQR Therapeutics) - Quarterly Revenue Growth|codexis.com (CDXS) - Quarterly Sales Growth Rate|Quarterly Revenue Growth SGMO|Quarterly Revenue Growth Nautilus Biotechnology, Inc. (NAUT)|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)